<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Yang Yang | PlatCOVID</title>
    <link>/author/yang-yang/</link>
      <atom:link href="/author/yang-yang/index.xml" rel="self" type="application/rss+xml" />
    <description>Yang Yang</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>BioHub - UFPE</copyright><lastBuildDate>Fri, 22 May 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu7e12209333f22d741aca7d462871821f_9877_512x512_fill_lanczos_center_2.png</url>
      <title>Yang Yang</title>
      <link>/author/yang-yang/</link>
    </image>
    
    <item>
      <title>A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.</title>
      <link>/publication/32404477/</link>
      <pubDate>Fri, 22 May 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32404477/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Artificial intelligence-enabled rapid diagnosis of patients with COVID-19.</title>
      <link>/publication/32427924/</link>
      <pubDate>Tue, 19 May 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32427924/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.</title>
      <link>/publication/32360286/</link>
      <pubDate>Sun, 03 May 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32360286/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.</title>
      <link>/publication/32346491/</link>
      <pubDate>Fri, 01 May 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32346491/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Distributions of time, place, and population of novel coronavirus disease 2019 (COVID-19) from January 20 to February 10, 2020, in China].</title>
      <link>/publication/32292205/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292205/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.</title>
      <link>/publication/32226288/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226288/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.</title>
      <link>/publication/31995857/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/31995857/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.</title>
      <link>/publication/32219428/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32219428/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.</title>
      <link>/publication/32048163/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32048163/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.</title>
      <link>/publication/32077789/</link>
      <pubDate>Thu, 20 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32077789/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
